Find your next paid study

Nemours Children's ClinicNCT05473013

Hypereosinophilic Syndrome

A Pilot Phase 2 Study of the Safety and Efficacy of Dupilumab as Add-on Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents

Background: Hypereosinophilic syndrome (HES) is a blood disorder that causes high levels of white blood cells called eosinophils. HES can damage the lungs and…

National Institute of Allergy and Infectious Diseases (NIAID)NCT06477653

~$10 – $5,625

Generalized Myasthenia Gravis

A Phase 2 Open-label Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children From 2 Years to Less Than 18 Years of Age With Generalized Myasthenia Gravis (gMG)

The primary objectives of this study are to characterize the pharmacokinetics (PK) and pharmacodynamics (PD) of inebilizumab administered in pediatric particip…

Respiratory Muscle Training During Cancer Treatment: Effects on the Autonomic Nervous System and Cardiotoxicity

This clinical trial evaluates whether home-based respiratory muscle training is useful for minimizing side effects in patients undergoing treatment for cancer.…

Breast CarcinomaHead and Neck CancerLung Cancer

Roswell Park Cancer InstituteNCT05787834

Breast CancerHER2-positive Breast Cancer

A Randomized Phase II Trial of Adjuvant Trastuzumab Emtansine (T-DM1) Followed by Subcutaneous Trastuzumab Versus Paclitaxel in Combination With Subcutaneous Trastuzumab for Stage I HER2-positive Breast Cancer (ATEMPT 2.0)

This research study is studying how well newly diagnosed breast cancer that has tested positive for a protein called HER2 responds using one of two different c…

Dana-Farber Cancer InstituteNCT04893109

Prostate CancerMalignant Neoplasm of ProstateSecondary Malignant Neoplasm of Prostate

Metastasis-directed Radiotherapy (MDRT) for Men With De-novo Oligometastatic Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

The purpose of this study is to find out if giving radiation therapy (RT) to areas of metastatic prostate cancer at the time a participant is diagnosed will he…

Case Comprehensive Cancer CenterNCT06150417

Skin Barrier DysfunctionHealthy Volunteers

Pilot Study of Fermented Papaya Preparation (FPP) Impact on Transepidermal Water Loss of Skin on Face, Arms, and Hands

This pilot study will test how Fermented Papaya Preparation (FPP) impacts overall TEWL of areas that commonly display diminished barrier function, such as the …

University of PittsburghNCT07725835

Adverse Childhood ExperiencesEndothelial Dysfunction

Adverse Childhood Experiences and Premature Vascular Aging in Humans: The Role of SIRT1

Adverse childhood experiences (ACEs) are directly related to cardiovascular morbidity and mortality, and impaired vascular endothelial function (VEF) is an ind…

University of Wisconsin, MadisonNCT07073352

Phase 1

A Phase IB, Single Dose, Open-Label, Dose-escalation Study to Investigate the Safety and Imaging Characteristics of Pemefolacianine for Intraoperative Molecular Imaging of Lung Cancer

The aim of this Phase 1b study is to investigate the safety and fluorescence signal of a single dose of Pemefolacianine for Injection, a novel fluorescence ima…

Lung Cancer (Locally Advanced or Metastatic)

Sunil SinghalNCT07772895

Chronic PainMusculoskeletal PainOlder Adults With Chronic Pain

Development and Preliminary Testing of a Peer Narrative Video Intervention for Older Adults With Chronic Pain

Chronic musculoskeletal (MSK) pain, which includes spinal pain, osteoarthritis, and fibromyalgia, is a common and costly problem for older adults and is associ…

Butler HospitalNCT07404618

Phase 3

CAMBRIA-1: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Extended Therapy With Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) in Patients With ER+/HER2- Early Breast Cancer and an Intermediate or High Risk of Recurrence Who Have Completed Definitive Locoregional Therapy and at Least 2 Years of Standard Adjuvant Endocrine-Based Therapy Without Disease Recurrence

This is a Phase III open-label study to assess if camizestrant improves outcomes compared to standard endocrine therapy in patients with ER+/HER2 - early breas…

Breast Cancer, Early Breast Cancer

AstraZenecaNCT05774951

Minimalist FootwearTraditional Foot Exercise ProgramFoot Strengthening Device (ToePro)+1 more

Evaluation of a Novel Foot Strengthening Device for Improving Fall Risk, Balance, and Gait With Age

The goal of this clinical trial is to learn whether different foot-strengthening strategies can improve foot strength, balance, walking ability, and fall-relat…